Processing

Please wait...

Settings

Settings

Goto Application

1. WO2022022630 - OXA-AZASPIRO DERIVATIVE, AND PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF

Publication Number WO/2022/022630
Publication Date 03.02.2022
International Application No. PCT/CN2021/109205
International Filing Date 29.07.2021
IPC
C07D 495/04 2006.1
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
495Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
02in which the condensed system contains two hetero rings
04Ortho-condensed systems
A61K 31/4162 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
41having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole
4151,2-Diazoles
4162condensed with heterocyclic ring systems
A61P 35/00 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
35Antineoplastic agents
CPC
A61K 31/4162
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
41having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
4151,2-Diazoles
4162condensed with heterocyclic ring systems
A61P 35/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
35Antineoplastic agents
C07D 495/04
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
495Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
02in which the condensed system contains two hetero rings
04Ortho-condensed systems
Applicants
  • 江苏恒瑞医药股份有限公司 JIANGSU HENGRUI MEDICINE CO., LTD. [CN]/[CN]
  • 上海恒瑞医药有限公司 SHANGHAI HENGRUI PHARMACEUTICAL CO., LTD. [CN]/[CN]
Inventors
  • 陆标 LU, Biao
  • 张蔡华 ZHANG, Caihua
  • 贺峰 HE, Feng
  • 陶维康 TAO, Weikang
Agents
  • 北京戈程知识产权代理有限公司 GE CHENG & CO., LTD
Priority Data
202010746651.029.07.2020CN
202010954059.X11.09.2020CN
202110210203.324.02.2021CN
Publication Language Chinese (zh)
Filing Language Chinese (ZH)
Designated States
Title
(EN) OXA-AZASPIRO DERIVATIVE, AND PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF
(FR) DÉRIVÉ OXA-AZASPIRO, SON PROCÉDÉ DE PRÉPARATION ET SON UTILISATION PHARMACEUTIQUE
(ZH) 氧杂氮杂螺环类衍生物、其制备方法及其在医药上的应用
Abstract
(EN) Disclosed are an oxa-azaspiro derivative, a preparation method therefor and a pharmaceutical use thereof. In particular, disclosed are an oxa-azaspiro derivative as represented by general formula (I), a preparation method therefor, a pharmaceutical composition containing the derivative, and the use thereof as a therapeutic agent, especially the use thereof as a PI3Kδ inhibitor and the use thereof in the preparation of a drug for treating diseases or conditions improved by means of inhibiting PI3Kδ.
(FR) L'invention concerne un dérivé oxa-azaspiro, son procédé de préparation et son utilisation pharmaceutique. En particulier, l'invention concerne un dérivé oxa-azaspiro tel que représenté par la formule générale (I), un procédé de préparation de celui-ci, une composition pharmaceutique contenant le dérivé, et son utilisation en tant qu'agent thérapeutique, en particulier son utilisation en tant qu'inhibiteur de PI3Kδ et son utilisation dans la préparation d'un médicament pour le traitement de maladies ou d'états améliorés par inhibition de PI3Kδ.
(ZH) 公开了一种氧杂氮杂螺环类衍生物、其制备方法及其在医药上的应用。具体而言,公开了一种通式(I)所示的氧杂氮杂螺环类衍生物、其制备方法及含有该衍生物的药物组合物以及其作为治疗剂的用途,特别是作为PI3Kδ抑制剂的用途和在制备用于治疗通过对PI3Kδ的抑制而改善的疾病或病症的药物中的用途。
Latest bibliographic data on file with the International Bureau